Drug Development Assignment for Multiple Drug Resistant Tuberculosis
Verified
Added on 2023/04/22
|4
|507
|216
AI Summary
This assignment focuses on drug development for multiple drug resistant tuberculosis using high throughput chemical screening process and targeting bacterial central metabolism system.
Contribute Materials
Your contribution can guide someone’s learning journey. Share your
documents today.
Running head: BIOLOGICAL SCIENCES DRUG DEVELOPMENT ASSIGNMENT Name of the Student Name of the University Author note
Secure Best Marks with AI Grader
Need help grading? Try our AI Grader for instant feedback on your assignments.
1BIOLOGICAL SCIENCES Bacterial Disease Infection toMycobacterium tuberculosisor MTB is one of the primary reasons for morbidity and mortality for the people of low-middle income countries because of increased resistance and hence, drug development against such resistance strains becomes one of the primarysourcesusingwhichsuchdiseasecouldbetreated(Colletal.2015).Hence, Tuberculosis, especially the multiple drug resistant tuberculosis (MDR-TB) will be chosen as the disease for drug development assignment. Source of Chemical Matter To treat MDR-TB, the target for the antibiotic should be the central bacteria metabolism system as this area of the drug discovery has very less amount of research and proposals. Success achieved in targeting bacterial central metabolism would emerge as a big discovery for the drugs associated to MDR-TB. Further, the chemical compound targeting the central metabolism of bacteria would be able to deplete the non-fermentable carbon source so that it could not use the non-fermentable carbon as the source. Therefore, this pathway will be chosen for this drug discovery (Murima, McKinney and Pethe 2014). Screening Approach High throughput chemical screening process will be used in the screening process of the new drug as it interacts with the bacterial influx system and it would be easier to understand the effectiveness of the source used, to affect the bacterial metabolism system. Therefore, this method of screen would be used to conduct the screening (Murima, McKinney and Pethe 2014).
2BIOLOGICAL SCIENCES Pre-Clinical Development The preclinical developmental stage of the new drug will start depending on its safety level, its effect on genetic level, and diagnostic tools in any adverse condition. This will hence, be inclusive of pharmacokinetics, pharmacodynamics and toxicology testing of the drug. After that the drug development will focus on the effect of the drug on animal samples and if found safe and effective the action of human tissue culture will be determined (Farha and Brown 2016).
3BIOLOGICAL SCIENCES References Coll, F., McNerney, R., Preston, M.D., Guerra-Assunção, J.A., Warry, A., Hill-Cawthorne, G., Mallard, K., Nair, M., Miranda, A., Alves, A. and Perdigão, J., 2015. Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences.Genome medicine,7(1), p.51. Farha, M.A. and Brown, E.D., 2016. Strategies for target identification of antimicrobial natural products.Natural product reports,33(5), pp.668-680. Murima, P., McKinney, J.D. and Pethe, K., 2014. Targeting bacterial central metabolism for drug development.Chemistry & biology,21(11), pp.1423-1432.